Developing Gold Nanoparticles Decorated With Carbon-Dots for Multiplexed Cellular Imaging

dc.contributor.author Kavuranpala, Tugce
dc.contributor.author Saydullaeva, Iroda
dc.contributor.author Ozcelik, Serdar
dc.date.accessioned 2025-11-25T15:11:37Z
dc.date.available 2025-11-25T15:11:37Z
dc.date.issued 2025
dc.description.abstract This study focuses on developing a novel hybrid nanomaterial composed of gold nanoparticle decorated with carbon dots, termed AuNP@C-dot, as a versatile platform for multiplexed imaging. Structural and spectral characterizations confirmed the successful conjugation of C-dots to AuNPs via covalent bonding, as evidenced by FTIR, X-ray photoelectron spectra, HRTEM analyses, and UV-Vis and fluorescence spectroscopies. The fluorescence intensities of C-dots are doubled through the conjugation to the AuNPs. The conjugation of fluorescent C-dots to plasmon-resonant AuNPs enables simultaneous multicellular imaging by taking advantage of the fluorescent signaling of C-dots and the scattering signaling of AuNPs. In vitro studies using human lung cell lines (A549 and BEAS-2B) confirmed the multiplexed imaging and revealed efficient cellular uptake and subcellular localization of AuNP@C-dots, including nuclear translocation, which is critical for radiotherapy and photodynamic therapy. Cell viability assessments utilizing a colorimetric assay for measuring cell metabolic activity and a colony formation assay demonstrated good biocompatibility of AuNP@C-dots at relevant concentrations. It can be envisioned that the AuNP@C-dot hybrid system may improve the detection and monitoring of cell health and disease due to its dual-modal imaging capability. Furthermore, they could be used for supervising controlled release of therapeutic agents, tailored for enhanced treatment efficacy. This study demonstrates the potential of C-dot-conjugated AuNPs as a multifunctional tool with inherent control mechanisms for the next-generation cellular analysis, drug administration, and diagnostic strategies. en_US
dc.description.sponsorship Turkiye Scientific and Technological Council [120N526]; EURONANOMED-124 [MATISSE] en_US
dc.description.sponsorship This work was supported by the Scientific and Technological Research Council of Turkiye (TUB & Idot;TAK, Project No. 120N526). The manuscript presents part of the findings obtained within the framework of the EURONANOMED Project MATISSE (MoleculAr harvesTing with electroporation and nanoparticles for dIagnoSticS and thErapy of heterogeneous solid tumors). en_US
dc.identifier.doi 10.1088/1361-6528/ae1508
dc.identifier.issn 0957-4484
dc.identifier.issn 1361-6528
dc.identifier.scopus 2-s2.0-105020634162
dc.identifier.uri https://doi.org/10.1088/1361-6528/ae1508
dc.identifier.uri https://hdl.handle.net/11147/18668
dc.language.iso en en_US
dc.publisher IOP Publishing Ltd en_US
dc.relation.ispartof Nanotechnology en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Carbon Dots en_US
dc.subject Gold Nanoparticles en_US
dc.subject Conjugation en_US
dc.subject Diagnosis en_US
dc.subject Cancer Therapy en_US
dc.subject Bioimaging en_US
dc.title Developing Gold Nanoparticles Decorated With Carbon-Dots for Multiplexed Cellular Imaging
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 60167617900
gdc.author.scopusid 58622288700
gdc.author.scopusid 7004257791
gdc.author.wosid Ozcelik, Serdar/S-4518-2016
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Kavuranpala, Tugce; Saydullaeva, Iroda; Ozcelik, Serdar] Izmir Inst Technol, Dept Chem, TR-35430 Urla Izmir, Turkiye; [Saydullaeva, Iroda] Samarkand State Univ, Engn Phys Inst, Samarkand, Uzbekistan en_US
gdc.description.issue 44 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.volume 36 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.openalex W4415366540
gdc.identifier.pmid 41115430
gdc.identifier.wos WOS:001605281900001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.openalex.collaboration International
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.34
gdc.opencitations.count 0
gdc.plumx.mendeley 1
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
gdc.wos.citedcount 0
relation.isAuthorOfPublication.latestForDiscovery ba0db351-faf1-4980-82bc-22e362fa795e
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4003-8abe-a4dfe192da5e

Files